General MedicationsORALStandard
MIFEPRISTONE
MIFEPRISTONE
Standard Dose
300MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview MIFEPRISTONE is listed in Drugs@FDA under application 211436 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient MIFEPRISTONE Form and strength TABLET;ORAL - 300MG Sponsor TEVA PHARMS USA INC Submission history Latest submission status date: 2020-08-03 00:00:00.
Structured Monograph
Clinical summary
Approval overview MIFEPRISTONE is listed in Drugs@FDA under application 211436 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient MIFEPRISTONE Form and strength TABLET;ORAL - 300MG Sponsor TEVA PHARMS USA INC Submission history Latest submission status date: 2020-08-03 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.